Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age.
Litvinenko. G I GI; Shurlygina. A V AV; Dergacheva. T I TI; Mel'nikova. E V EV; Trufakin. V A VA
Key Findings
- Lymphocyte SDH activity shows a clear daily (diurnal) pattern.
- Women whose blood cells responded to thymalin/ridostin with increased SDH activity showed greater clinical and lab improvements.
- Timing the drug when SDH activity is high may maximize its immunomodulatory effect.
Practical Outcomes
- For self‑experimenters, the takeaway is that the timing of thymalin dosing could matter—administer it when your immune cells are most responsive, likely during the peak SDH activity period (often in the morning). While the study doesn’t give exact dosing, it suggests monitoring personal energy or immune markers and aligning peptide intake accordingly. Start with a low dose and adjust timing based on how you feel or any measurable changes.
Summary
The study looked at women with chronic pelvic infections and found that the immune‑boosting peptide thymalin (and a similar drug, ridostin) works better when the blood cells’ enzyme SDH is active. This enzyme’s activity changes throughout the day, so giving the peptide at the right time could improve outcomes.
Abstract
We compared the effectiveness of immunomodulators used in the treatment of patients with chronic salpingitis and oophoritis with or without changes in succinate dehydrogenase (SDH) activity in blood lymphocytes at incubation with the drug. Diurnal variations in individual reaction of SDH in blood lymphocytes to thymalin or ridostin were revealed. In the groups of women receiving ridostin or thymalin during the reaction of lymphocyte SDH to it, improvement of clinical laboratory and immunological parameters was observed in the majority of the patients and no effect was found in a lesser group of patients than in the groups treated with drugs during the absence of lymphocyte SDH reaction thereto. The timing of the presence of SDH reaction to drugs in the immunocompetent cells makes it possible to set the optimal daily regime of their application and to select a drug that would be most effective in each particular case.
Study Information
pubmed
2015
2015-06-03T00:00:00.000Z
10.1007/s10517-015-2890-0
3
17